Given the rising incidence of colorectal cancer — particularly among younger adults — and ongoing threats to preventive screening in the U.S., the need for timely, optimized CRC screening is greater than ever.
Colonoscopy continues to be the gold standard for CRC screening in the U.S. It has an approximate sensitivity of 95% for detecting CRC and allows gastroenterologists to detect and remove potentially precancerous polyps. While this method is invasive, costlier and initially more onerous to patients, who are required to take time off from work and undergo bowel preparation and